BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/24/2023 9:09:47 AM | Browse: 334 | Download: 959
 |
Received |
|
2022-11-02 17:42 |
|
Peer-Review Started |
|
2022-11-02 17:44 |
|
First Decision by Editorial Office Director |
|
2022-11-24 05:32 |
|
Return for Revision |
|
2022-11-27 04:48 |
|
Revised |
|
2022-12-20 09:09 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2023-01-31 03:25 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2023-01-31 04:02 |
|
Articles in Press |
|
2023-01-31 04:02 |
|
Edit the Manuscript by Language Editor |
|
2023-01-24 13:33 |
|
Typeset the Manuscript |
|
2023-02-01 16:41 |
|
Publish the Manuscript Online |
|
2023-02-24 09:09 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Implications of metabolic dysfunction associated fatty liver disease in COVID-19
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Raja Chakraborty, Deepak Sharma, Devesh U Kapoor, Akanksha Dwivedi, Rakhi Khabiya and Saikat Sen |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Saikat Sen, PhD, Professor, Faculty of Pharmaceutical Science, Assam down town University, Gandhinagar, Panikhaiti, Guwahati 781026, Assam, India. saikat.pharm@rediffmail.com |
| Key Words |
Metabolic associated fatty liver disorder; COVID-19; Metabolic dysfunction; Hepatic damage; Cytokine storm |
| Core Tip |
Metabolic associated fatty liver disorder (MAFLD) is associated with fat accumulation and inflammation in hepatocytes, thus compromising liver function and making people more susceptible to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Therefore, cytokine storm in SARS-CoV-2 infected MAFLD patients is considered severe and requires urgent attention. In addition, direct hepatic injury caused by SARS-CoV-2, enhanced levels of inflammatory cytokines, declined hepatic mitochondrial activity, compromised immunity, and altered expression of host angiotensin-converting enzyme 2 receptor are considered as some underlying mechanisms. Thus, patients with MAFLD require special attention to protect themselves from the SARS-CoV-2 infection or severe illness caused by SARS-CoV-2. |
| Publish Date |
2023-02-24 09:09 |
| Citation |
Chakraborty R, Sharma D, Kapoor DU, Dwivedi A, Khabiya R, Sen S. Implications of metabolic dysfunction associated fatty liver disease in COVID-19. World J Clin Cases 2023; 11(6): 1275-1286 |
| URL |
https://www.wjgnet.com/2307-8960/full/v11/i6/1275.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v11.i6.1275 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
